journal article·2023-08-01Open access

Research Progress on Nanomaterials for Tissue Engineering in Oral Diseases

Tong Jiang, Wen Su, Yan Li, Mingyuan Jiang, Yonghong Zhang, Cory J. Xian, Yuankun Zhai

Abstract

Due to their superior antibacterial properties, biocompatibility and high conductivity, nanomaterials have shown a broad prospect in the biomedical field and have been widely used in the prevention and treatment of oral diseases. Also due to their small particle sizes and biodegradability, nanomaterials can provide solutions for tissue engineering, especially for oral tissue rehabilitation and regeneration. At present, research on nanomaterials in the field of dentistry focuses on the biological effects of various types of nanomaterials on different oral diseases and tissue engineering applications. In the current review, we have summarized the biological effects of nanoparticles on oral diseases, their potential action mechanisms and influencing factors. We have focused on the opportunities and challenges to various nanomaterial therapy strategies, with specific emphasis on overcoming the challenges through the development of biocompatible and smart nanomaterials. This review will provide references for potential clinical applications of novel nanomaterials in the field of oral medicine for the prevention, diagnosis and treatment of oral diseases.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Oral microbiology and periodontitis research · Bone Tissue Engineering Materials · Nanoplatforms for cancer theranostics

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

School of Stomatology, Henan University, Kaifeng 475000, China

Kaifeng Key Laboratory of Periodontal Tissue Engineering, Kaifeng 475000, China

Department of Pharmacy, Huaihe Hospital, Henan University, Kaifeng 475000, China

Department of Orthopaedics, The 2nd Hospital of Shanxi Medical University, Taiyuan 030001, China

UniSA Clinical and Health Sciences, University of South Australia, Adelaide, SA 5001, Australia

Funding

Foundation of Science and Technology Department of Henan Province, China · Natural Science Foundation of Education Department of Henan Province, China · Foundation of the National Health Commission of Henan Province, China · Foundation of the Educational Administration Department of Henan University, China · Foundation of Science and Technology Department of Kaifeng City, Henan Province, China

References (100+)

Show source-provided references
1. Drug delivery systems for oral disease applications10.1590/1678-7757-2021-0349 ↗
2. Oral microbiota in human systematic diseases10.1038/s41368-022-00163-7 ↗
3. Relationships Between Oral Microecosystem and Respiratory Diseases10.3389/fmolb.2021.718222 ↗
4. Nomura, Y., Okada, A., and Hanada, N. (2022). Future Prospective of Oral Microbiome Research. Appl. Sci., 12.10.3390/app12010055 ↗
5. Tissue Engineering in Stomatology: A Review of Potential Approaches for Oral Disease Treatments10.3389/fbioe.2021.662418 ↗
6. The Oral Microbiome and Cancer10.3389/fimmu.2020.591088 ↗
7. Advances and challenges in oral biofilm control10.1007/s40496-017-0120-8 ↗
8. Liu, H., Jie, Y., and Han, X. (2020). 181 Anlyasis of therapeutic effect and safty of PD-1 inhibitors in clinical treatment of oral and maxillofacial malignant tumors. J. ImmunoTherapy Cancer, 8.10.1136/jitc-2020-SITC2020.0181 ↗
9. Periodontitis and cardiovascular diseases: Consensus report10.1111/jcpe.13189 ↗
10. Bone morphogenetic proteins: Signaling periodontal bone regeneration and repair10.4103/0975-7406.191964 ↗
11. Abedi, N., Sajadi-Javan, Z.S., Kouhi, M., Ansari, L., Khademi, A., and Ramakrishna, S. (2023). Antioxidant Materials in Oral and Maxillofacial Tissue Regeneration: A Narrative Review of the Literature. Antioxidants, 12.10.3390/antiox12030594 ↗
12. Global, Regional, and National Levels and Trends in Burden of Oral Conditions from 1990 to 2017: A Systematic Analysis for the Global Burden of Disease 2017 Study10.1177/0022034520908533 ↗
13. Advanced materials and technologies for oral diseases10.1080/14686996.2022.2156257 ↗
14. Role of Dentistry in Global Health: Challenges and Research Priorities10.1177/0022034521992011 ↗
15. Advanced biomaterials and their potential applications in the treatment of periodontal disease10.3109/07388551.2015.1035693 ↗
16. Eid, A., Mancino, D., Rekab, M.S., Haikel, Y., and Kharouf, N. (2022). Effectiveness of Three Agents in Pulpotomy Treatment of Permanent Molars with Incomplete Root Development: A Randomized Controlled Trial. Healthcare, 10.10.3390/healthcare10030431 ↗
17. Engineering precision nanoparticles for drug delivery10.1038/s41573-020-0090-8 ↗
18. Analysis of nanoparticle delivery to tumours10.1038/natrevmats.2016.14 ↗
19. Unmet needs in developing nanoparticles for precision medicine10.2217/nnm-2016-0390 ↗
20. Breaking Down the Barriers to Precision Cancer Nanomedicine10.1016/j.tibtech.2016.07.006 ↗
21. Silencing or stimulation? siRNA delivery and the immune system10.1146/annurev-chembioeng-061010-114133 ↗
22. Nanotechnology-enabled gene delivery for cancer and other genetic diseases10.1080/17425247.2023.2200246 ↗
23. Pharmacokinetics, biodistribution and cell uptake of antisense oligonucleotides10.1016/j.addr.2015.01.008 ↗
24. Influence of particle size and shape on their margination and wall-adhesion: Implications in drug delivery vehicle design across nano-to-micro scale10.1039/C8NR04042G ↗
25. The effect of nanoparticle size on in vivo pharmacokinetics and cellular interaction10.2217/nnm.16.5 ↗
26. Hanssen, A., Riebensahm, C., Mohme, M., Joosse, S.A., Velthaus, J.L., Berger, L.A., Bernreuther, C., Glatzel, M., Loges, S., and Lamszus, K. (2018). Frequency of Circulating Tumor Cells (CTC) in Patients with Brain Metastases: Implications as a Risk Assessment Marker in Oligo-Metastatic Disease. Cancers, 10.10.3390/cancers10120527 ↗
27. Cation-Free siRNA Micelles as Effective Drug Delivery Platform and Potent RNAi Nanomedicines for Glioblastoma Therapy10.1002/adma.202104779 ↗
28. Drug Delivery (Nano)Platforms for Oral and Dental Applications: Tissue Regeneration, Infection Control, and Cancer Management10.1002/advs.202004014 ↗
29. Diagnostic pathology of early systemic cancer: ERBB2 gene amplification in single disseminated cancer cells determines patient survival in operable esophageal cancer10.1002/ijc.31108 ↗
30. Advances in siRNA delivery in cancer therapy10.1080/21691401.2017.1307210 ↗
31. Transferrin receptor-targeted theranostic gold nanoparticles for photosensitizer delivery in brain tumors10.1039/C4NR04853A ↗
32. Nano-based delivery of RNAi in cancer therapy10.1186/s12943-017-0683-y ↗
33. Endogenous Stimuli-responsive Nanocarriers for Drug Delivery10.1246/cl.151176 ↗
34. The oral microbiota: Dynamic communities and host interactions10.1038/s41579-018-0089-x ↗
35. Characterization of Polymeric Nanoparticle Dispersions for Biomedical Applications: Size, Surface Charge and Stability10.2174/2211738506666180706121515 ↗
36. Aunps and Agμps-functionalized zirconia surfaces by hybrid laser technology for dental implants10.1016/j.ceramint.2019.11.203 ↗
37. Selective cytotoxicity of green synthesized silver nanoparticles against the MCF-7 tumor cell line and their enhanced antioxidant and antimicrobial properties10.2147/IJN.S189295 ↗
38. Antibacterial properties of nanoparticles10.1016/j.tibtech.2012.06.004 ↗
39. “Nanoantibiotics”: A new paradigm for treating infectious diseases using nanomaterials in the antibiotics resistant era10.1016/j.jconrel.2011.07.002 ↗
40. Nanotechnology in dentistry: Prevention, diagnosis, and therapy
41. Antimicrobial and Anti-Inflammatory Activity of Chitosan–Alginate Nanoparticles: A Targeted Therapy for Cutaneous Pathogens10.1038/jid.2012.399 ↗
42. The growing role of nanotechnology in combating infectious disease10.4161/viru.2.5.17035 ↗
43. Nanotechnology and its role in caries therapy10.1177/0022034512450446 ↗
44. Lopez-Piriz, R., Sola-Linares, E., Rodriguez-Portugal, M., Malpica, B., Diaz-Guemes, I., Enciso, S., Esteban-Tejeda, L., Cabal, B., Granizo, J.J., and Moya, J.S. (2015). Evaluation in a Dog Model of Three Antimicrobial Glassy Coatings: Prevention of Bone Loss around Implants and Microbial Assessments. PLoS ONE, 10.10.1371/journal.pone.0140374 ↗
45. Nanotechnology in ligature-induced periodontitis: Protective effect of a doxycycline gel with nanoparticules10.1590/S1678-77572010000400003 ↗
46. Antibacterial and remineralizing nanocomposite inhibit root caries biofilms and protect root dentin hardness at the margins10.1016/j.jdent.2020.103344 ↗
47. Novel dental adhesives containing nanoparticles of silver and amorphous calcium phosphate10.1016/j.dental.2012.10.005 ↗
48. The oral microbiome—Friend or foe?10.1111/eos.12527 ↗
49. Oral Tissue Engineering Progress and Challenges10.1007/s13770-015-0030-6 ↗
50. The oral microbiome in health and disease10.1016/j.phrs.2012.11.006 ↗
51. Corrigendum to “Understanding the role of gut microbes and probiotics in obesity: How far are we?” [Pharmacol. Res. 69 (2013) 144–155]10.1016/j.phrs.2013.02.006 ↗
52. A review of saliva: Normal composition, flow, and function10.1067/mpr.2001.113778 ↗
53. Periodontitis: A polymicrobial disruption of host homeostasis10.1038/nrmicro2337 ↗
54. Systemic diseases caused by oral infection10.1128/CMR.13.4.547 ↗
55. Current advances in the use of exosomes, liposomes, and bioengineered hybrid nanovesicles in cancer detection and therapy10.1038/s41401-022-00902-w ↗
56. Cancer nanomedicine: Progress, challenges and opportunities10.1038/nrc.2016.108 ↗
57. Ye, F., Zhu, Z.D., Gu, Y.C., Li, J., Zhu, W.L., and Guo, Y.W. (2018). Further New Diterpenoids as PTP1B Inhibitors from the Xisha Soft Coral Sinularia polydactyla. Mar. Drugs, 16.10.3390/md16040103 ↗
58. Perspectives for the use of silver nanoparticles in dental practice10.1111/j.1875-595X.2011.00072.x ↗
59. Saliva: An emerging biofluid for early detection of diseases
60. A highly sensitive uric acid electrochemical biosensor based on a nano-cube cuprous oxide/ferrocene/uricase modified glassy carbon electrode10.1038/s41598-020-67394-8 ↗
61. Ultrasensitive antibody-aptamer plasmonic biosensor for malaria biomarker detection in whole blood10.1038/s41467-020-19755-0 ↗
62. Label-free biomarker detection from whole blood10.1038/nnano.2009.353 ↗
63. Nanobiosensors: Point-of-care approaches for cancer diagnostics10.1016/j.bios.2019.01.034 ↗
64. Measurement of biomarker proteins for point-of-care early detection and monitoring of cancer10.1039/c0an00204f ↗
65. In Situ Formation of Nanotheranostics to Overcome the Blood-Brain Barrier and Enhance Treatment of Orthotopic Glioma10.1021/acsami.0c03873 ↗
66. Microbubble-enhanced ultrasound for the antivascular treatment and monitoring of hepatocellular carcinoma10.7150/ntno.39514 ↗
67. Magnetic Nanoliposomes as in Situ Microbubble Bombers for Multimodality Image-Guided Cancer Theranostics10.1021/acsnano.6b06815 ↗
68. Fatima, T., Khurshid, Z., Rehman, A., Imran, E., Srivastava, K.C., and Shrivastava, D. (2021). Gingival Crevicular Fluid (GCF): A Diagnostic Tool for the Detection of Periodontal Health and Diseases. Molecules, 26.10.3390/molecules26051208 ↗
69. Analysis of inorganic ions in gingival crevicular fluid as indicators of periodontal disease activity: A clinico-biochemical study10.4103/0976-237X.91788 ↗
70. New sensor based on membranes with magnetic nano-inclusions for early diagnosis in periodontal disease10.1016/j.bios.2017.11.003 ↗
71. Nanotechnology and its application in dentistry10.4103/2141-9248.141951 ↗
72. Nanorobots: Future in dentistry10.1016/j.sdentj.2012.12.002 ↗
73. Gene Specific DNA Sensors for Diagnosis of Pathogenic Infections10.1007/s12088-017-0650-8 ↗
74. Nanotechnology in dentistry: Present and future
75. Gold Nanorods Based Air Scanning Electron Microscopy and Diffusion Reflection Imaging for Mapping Tumor Margins in Squamous Cell Carcinoma10.1021/acsnano.5b07114 ↗
76. Diffusion Reflection Method for Early Detection of Oral Squamous Cell Carcinoma Specifically Targeted by Circulating Gold-Nanorods Bio-Conjugated to Anti-Epidermal Growth Factor Receptor10.2147/IJN.S300125 ↗
77. Development of targeted therapy for bladder cancer mediated by a double promoter plasmid expressing diphtheria toxin under the control of H19 and IGF2-P4 regulatory sequences10.1186/1479-5876-8-134 ↗
78. Nanocarriers as an emerging platform for cancer therapy10.1038/nnano.2007.387 ↗
79. Kang, T.H., Mao, C.P., He, L., Tsai, Y.C., Liu, K., La, V., Wu, T.C., and Hung, C.F. (2012). Tumor-targeted delivery of IL-2 by NKG2D leads to accumulation of antigen-specific CD8+ T cells in the tumor loci and enhanced anti-tumor effects. PLoS ONE, 7.10.1371/journal.pone.0035141 ↗
80. Wei, L., Wen, X.S., and Xian, C.J. (2021). Chemotherapy-Induced Intestinal Microbiota Dysbiosis Impairs Mucosal Homeostasis by Modulating Toll-like Receptor Signaling Pathways. Int. J. Mol. Sci., 22.10.3390/ijms22179474 ↗
81. New Directions for Drug Delivery in Cancer Therapy10.1021/acs.molpharmaceut.8b00860 ↗
82. The siRNAsome: A cation-free and versatile nanostructure for siRNA and drug co-delivery10.1002/anie.201814289 ↗
83. Development of a multifunctional gold nanoplatform for combined chemo-photothermal therapy against oral cancer10.2217/nnm-2019-0415 ↗
84. Engineered Protein Photo-Thermal Hydrogels for Outstanding In Situ Tongue Cancer Therapy10.1002/adma.202100619 ↗
85. Differential localization of PD-L1 and Akt-1 involvement in radioresistant and radiosensitive cell lines of head and neck squamous cell carcinoma10.1093/carcin/bgz177 ↗
86. Immunomodulatory aspects in the progression and treatment of oral malignancy10.1016/j.jdsr.2019.09.001 ↗
87. An update of knowledge on PD-L1 in head and neck cancers: Physiologic, prognostic and therapeutic perspectives10.1111/odi.13088 ↗
88. Immunohistochemical Study of PD-1/PD-L1 Axis Expression in Oral Tongue Squamous Cell Carcinomas: Effect of Neoadjuvant Chemotherapy on Local Recurrence10.1007/s12253-019-00606-3 ↗
89. Oral mucositis: The hidden side of cancer therapy10.1186/s13046-020-01715-7 ↗
90. Sonaje, K., Tyagi, V., Chen, Y., and Kalia, Y.N. (2021). Iontosomes: Electroresponsive Liposomes for Topical Iontophoretic Delivery of Chemotherapeutics to the Buccal Mucosa. Pharmaceutics, 13.10.3390/pharmaceutics13010088 ↗
91. Evaluation of the antiapoptotic and anti-inflammatory properties of chitosan in methotrexate-induced oral mucositis in rats10.1007/s11033-022-07158-x ↗
92. Buccal adhesive nanofibers containing human growth hormone for oral mucositis10.1002/jbm.b.33487 ↗
93. Electrospun polycaprolactone nanofibers as a potential oromucosal delivery system for poorly water-soluble drugs10.1016/j.ejps.2015.04.004 ↗
94. Bioactive materials in endodontics10.1586/17434440.5.4.475 ↗
95. Active Nanomaterials to Meet the Challenge of Dental Pulp Regeneration10.3390/ma8115387 ↗
96. Vascularized pulp regeneration via injecting simvastatin functionalized GelMA cryogel microspheres loaded with stem cells from human exfoliated deciduous teeth10.1016/j.mtbio.2022.100209 ↗
97. Conversion of stem cells from apical papilla into endothelial cells by small molecules and growth factors10.1186/s13287-021-02350-5 ↗
98. Antibacterial Nanoparticles in Endodontics: A Review10.1016/j.joen.2016.05.021 ↗
99. Semiconducting Polymer Nanoparticles with Intramolecular Motion-Induced Photothermy for Tumor Phototheranostics and Tooth Root Canal Therapy10.1002/adma.202200179 ↗
100. Novel endodontic sealer with dual strategies of dimethylaminohexadecyl methacrylate and nanoparticles of silver to inhibit root canal biofilms10.1016/j.dental.2019.05.014 ↗